Company intelligence / Profile preview

Integrum

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Integrum has developed and commercialized the OPRA™ Implant System, a pioneering bone-anchored prosthesis solution that enables direct skeletal attachment of artificial limbs. The system has been in clinical use since 1990 and continues to be refined through ongoing research. Clinical results highlight improved mobility, comfort, and quality of life for amputees compared to traditional socket-based solutions.

Therapeutic areas: OtherCardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Collaborations with academic centers/hospitals globally for clinical research on osseointegration.Partnerships with clinicians and rehabilitation centers internationally.

Beyond the preview

Go deeper on Integrum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrum.

Explore the full profile